Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revolutionized management in obesity and diabetes, showing better metabolic outcomes, and their use is increasingly common among plastic surgery patients [1-4]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.